Wednesday - December 25, 2024

Substituted Diaminocarboxamide and Diaminocarbonitrile Pyrimidines, Compositions Thereof, and Methods of Treatment Therewith

2024-10-29

ALEXANDRIA, Virginia, Oct. 29 -- SIGNAL PHARMACEUTICALS, LLC, San Diego, California has been assigned a patent (No. US 12129237 B2, initially filed March 29, 2022) developed by sixteen inventors Brydon L. Bennett, San Diego, California; Mercedes Delgado, San Diego, California; Jan Elsner, Solana Beach, California; Paul Erdman, San Diego, California; Robert Hilgraf, San Diego, California; Laurie Ann LeBrun, San Diego, California; Meg McCarrick, San Diego, California; Mehran F. Moghaddam, Carlsbad . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Substituted Diaminocarboxamide and Diaminocarbonitrile Pyrimidines, Compositions Thereof, and Methods of Treatment Therewith

Information Request Form

Copyright Targeted News Service 2024